Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Research And Views Archives | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!


Unichem: Strong growth

(Jun 20, 2002)

A wider therapeutic reach, increasing presence in exports and restructuring benefits have helped Unichem Labs display robust numbers for FY02. The company's margins have shown steady improvement in the last two years due to product introductions in high growth segments. The company ended FY02 with a 55% growth in net profits.

Unichem: Restructuring pays off

(Sep 21, 2001)

The restructuring exercise initiated by Unichem Laboratories seems to be bearing fruit. The company's margins have shown steady improvement in the last two years due to high margin product introductions and increasing focus on exports. The company's domestic formulations business grew by a robust 22.8% last fiscal.

Interest reduction, other income boost bottomline

(Jan 20, 2000)

Unichem has reported an impressive growth in earnings by 47.3%. The turnover has improved by 3.6% as compared to the third quarter last year and the company has managed to control rise in expenditure to 5%. Overall, formulation sales are under pressure and Unichem is no exception to the general trend in the pharmaceutical sector. The growth in bottomline has been led by the reduction in the interest costs.

Unichem Labs posts 35.7% jump in net

(Oct 26, 1999)

Unichem Labs sales (Rs 564 m) appreciated 8.7% in 2QFY2000. A 35.7% leap in net profit effected a rise in net profit margin to 8.7% (6.9%).

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms